Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

Clinical trial NCT01908556 · UNKNOWN

Trial details

NCT number: NCT01908556
Sponsor: Institut fuer Frauengesundheit
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Start date: 2009-02-01
Primary completion: 2015-12-01
Enrollment: 3545

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.